Inventor · disambiguated record
Nicholas W. Warne
Also filed as: WARNE NICHOLAS W · WARNE NICHOLAS WILLIAM · WARNE Nicholas
17 granted patents·27 pending applications·1,099 citations·filing 1994–2021
96Inventor score
Top patents by PatentIndex Score
44 records- 0198US6914128B1Human antibodies that bind human IL-12 and methods for producingABBOTT GMBH & CO KG·Filed 2000·Granted Jul 5, 2005·567 cites·74 claims
- 0296US7883704B2Methods for inhibiting the activity of the P40 subunit of human IL-12ABBOTT GMBH & CO KG·Filed 2006·Granted Feb 8, 2011·68 cites·66 claims
- 0396US7504485B2Human antibodies that bind human IL-12ABBOTT GMBH & CO KG·Filed 2004·Granted Mar 17, 2009·71 cites·51 claims
- 0494US7635473B2Anti Aβ antibody formulationJANSSEN ALZHEIMER IMMUNOTHERAP·Filed 2006·Granted Dec 22, 2009·52 cites·28 claims
- 0594US7390786B2Protein formulations with reduced viscosity and uses thereofWYETH CORP·Filed 2006·Granted Jun 24, 2008·66 cites·36 claims
- 0693US7758860B2Protein formulations with reduced viscosity and uses thereofWYETH LLC·Filed 2008·Granted Jul 20, 2010·44 cites·19 claims
- 0790US6540993B1Method of treating inflammatory bowel disease using a topical formulation of IL-11INST GENETICS LLC·Filed 2000·Granted Apr 1, 2003·44 cites·12 claims
- 0886US5744132AFormulations for IL-12GENETICS INST·Filed 1997·Granted Apr 28, 1998·105 cites·4 claims
- 0985US8318164B2Anti A beta antibody formulationWARNE NICHOLAS W·Filed 2009·Granted Nov 27, 2012·16 cites·52 claims
- 1083US7449444B2Hydroxyethyl starch-containing polypeptide compositionsWYETH CORP·Filed 2005·Granted Nov 11, 2008·6 cites·9 claims
- 1176US9884019B2Lyophilization above collapseTCHESSALOV SERGUEI·Filed 2009·Granted Feb 6, 2018·2 cites·38 claims
- 1275US8865174B2Methods of treatment using human antibodies that bind IL-12SALFELD JOCHEN G·Filed 2012·Granted Oct 21, 2014·1 cites·62 claims
- 1375US6982080B2Hydroxyethyl starch—containing polypeptide compositionsUNIV COLORADO·Filed 2003·Granted Jan 3, 2006·7 cites·28 claims
- 1475US6270757B1Formulations for IL-11GENETICS INST·Filed 1994·Granted Aug 7, 2001·42 cites·20 claims
- 1574US8765918B2Human antibodies that bind human interleukin-12SALFELD JOCHEN G·Filed 2012·Granted Jul 1, 2014·1 cites·46 claims
- 1673US7033992B2Formulations for IL-11INST GENETICS LLC·Filed 2001·Granted Apr 25, 2006·7 cites·24 claims
- 1769US2009269302A1Human antibodies that bind human il-12 and methods for producingABBOTT GMBH & CO KG·Filed 2009·Application pending·0 cites
- 1868US2009175857A1Human Antibodies That Bind Human IL-12 And Methods For ProducingABBOTT GMBH & CO KG·Filed 2008·Application pending·0 cites
- 1959US2010172862A1Stable antibody compositions and methods of stabilizing sameABBOTT LAB·Filed 2009·Application pending·0 cites
- 2059US2005008580A1Hemophilia treatment by inhalation of coagulation factorsWYETH CORP·Filed 2004·Application pending·0 cites
- 2159US2009185996A1Hydroxyethyl starch-containing polypeptide compositionsWARNE NICHOLAS W·Filed 2008·Application pending·0 cites
- 2257US2008200656A1Use Of Sucrose To Suppress Mannitol-Induced Protein AggregationWYETH CORP·Filed 2008·Application pending·0 cites
- 2357US2010062058A1Delayed Release Formulations for Oral Administration of a Polypeptide Therapeutic Agent and Methods of Using SameWYETH CORP·Filed 2009·Application pending·0 cites
- 2456US9035030B2Human antibodies that bind the P40 subunit of human IL-12 and methods for using the sameSALFELD JOCHEN·Filed 2012·Granted May 19, 2015·0 cites·18 claims
- 2556US2009324586A1Lyophilization cycle robustness strategyWYETH CORP·Filed 2009·Application pending·0 cites
- 2655US2006159656A1Formulations for IL-11AMERICAN HOME PROD·Filed 2005·Application pending·0 cites
- 2754US2008098614A1Lyophilization methods and apparatusesWYETH CORP·Filed 2007·Application pending·0 cites
- 2852US2012201831A1Human antibodies that bind human il-12 and methods for producingSALFELD JOCHEN G·Filed 2012·Application pending·0 cites
- 2952US2008064856A1Methods for reducing protein aggregationWYETH CORP·Filed 2007·Application pending·0 cites
- 3052US2015071944A1Stable antibody compositions and methods of stabilizing sameABBVIE INC·Filed 2014·Application pending·0 cites
- 3152US2011091415A1Hydroxyethyl Starch-Containing Polypeptide CompositionsWYETH CORP·Filed 2010·Application pending·0 cites
- 3251US2012134958A1Hydroxyethyl starch-containing polypeptide compositionsWARNE NICHOLAS W·Filed 2012·Application pending·0 cites
- 3350US2010124536A1Hemophilia Treatment by Inhalation of Coagulation FactorsWYETH CORP·Filed 2010·Application pending·0 cites
- 3449US2011123544A1Human antibodies that bind human il-12 and methods for producingABBOTT GMBH & CO KG·Filed 2010·Application pending·0 cites
- 3548US2007237758A1Immunoglobulin fusion protein formulationsBARRY ANTHONY·Filed 2006·Application pending·0 cites
- 3648US2004126358A1Delayed release formulations for oral administration of a polypeptide therapeutic agent and methods of using sameFiled 2003·Application pending·0 cites
- 3747US2008070230A1Methods for reducing or preventing liquid-liquid phase separation in high concentration protein solutionsWYETH CORP·Filed 2007·Application pending·0 cites
- 3847US2008003686A1Prediction of relative polypeptide solubility by polyethylene glycol precipitationWYETH CORP·Filed 2007·Application pending·0 cites
- 3947US2003147849A1Topical formulations for delivery of interleukin-11WYETH CORP·Filed 2003·Application pending·0 cites
- 4047US2011027292A1Protein Formulations with Reduced Viscosity and Uses ThereofWYETH LLC·Filed 2010·Application pending·0 cites
- 4146US2024002127A1Coronavirus vaccinePFIZER·Filed 2021·Application pending·0 cites
- 4243US2011033464A1Immunoglobulin fusion protein formulationsWYETH CORP·Filed 2010·Application pending·0 cites
- 4340US2006210557A1Stabilized liquid polypeptide formulationsLUISI DONNA·Filed 2006·Application pending·0 cites
- 4427US2012114646A1Lyophilized formulations for small modular immunopharmaceuticalsTCHESSALOV SERGUEI·Filed 2010·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Nicholas W. Warne files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →